NRD
EW icon

Nebula Research & Development’s Edwards Lifesciences EW Stock Holding History

Nebula Research & Development’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-31,471
Closed -$2.46M – 315
2025
Q2 		$2.46M Sell
31,471
-16,819
-35% -$1.25M 0.21% 141
2025
Q1 		$3.5M Buy
+48,290
New +$3.46M 0.32% 60
2024
Q4 		– Sell
-11,927
Closed -$787K – 964
2024
Q3 		$787K Buy
+11,927
New +$867K 0.09% 395

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Nebula Research & Development's EW Position: Q3 2025 in Review

Nebula Research & Development sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 31,471 shares — an estimated $2.46M sold.

Nebula Research & Development first reported a position in EW in Q3 2024 and held it in 3 quarters. The position peaked at $3.5M in Q1 2025. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Nebula Research & Development reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 31,471 Edwards Lifesciences shares in Q3 2025, an estimated $2.46M.
  • Nebula Research & Development first reported a position in Edwards Lifesciences in Q3 2024 and held it in 3 quarters.
  • Nebula Research & Development's Edwards Lifesciences position peaked at $3.5M in Q1 2025.
  • 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.